Circulating metabolomics profiling reveals novel pathways associated with cognitive decline in patients with hypertension.
Yuli HuangHaoxiao ZhengKuan TanXiangdong SunJinshao YeYunlong ZhangPublished in: Therapeutic advances in neurological disorders (2020)
Our study provides a novel metabolic and microbial mechanism, which may underlie the cognitive impairment in hypertensive patients.